Michael Joseph Golembiewski - 28 Feb 2023 Form 4 Insider Report for SEELOS THERAPEUTICS, INC.

Role
Chief Financial Officer
Signature
/s/ Michael Golembiewski
Issuer symbol
N/A
Transactions as of
28 Feb 2023
Net transactions value
+$8,400
Form type
4
Filing time
02 Mar 2023, 15:06:15 UTC
Previous filing
04 Mar 2022
Next filing
31 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SEEL Common Stock Award $8,400 +12,500 +16% $0.6720 90,987 28 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Company's 2020 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).